Your browser doesn't support javascript.
loading
Plasma treatment causes structural modifications in lysozyme, and increases cytotoxicity towards cancer cells.
Attri, Pankaj; Kaushik, Nagendra Kumar; Kaushik, Neha; Hammerschmid, Dietmar; Privat-Maldonado, Angela; De Backer, Joey; Shiratani, Masaharu; Choi, Eun Ha; Bogaerts, Annemie.
Afiliación
  • Attri P; Center of Plasma Nano-interface Engineering, Kyushu University, Fukuoka 819-0395, Japan; Graduate School of Information Science and Electrical Engineering, Kyushu University, Fukuoka 819-0395, Japan; Research Group PLASMANT, Department of Chemistry, University of Antwerp, Antwerp, Belgium. Electroni
  • Kaushik NK; Department of Electrical and Biological Physics, Kwangwoon University, Seoul 01897, Republic of Korea.
  • Kaushik N; Department of Biotechnology, College of Engineering, University of Suwon, Hwaseong 18323, Republic of Korea.
  • Hammerschmid D; Research Group PPES, Department of Biomedical Sciences, University of Antwerp, Universiteitsplein 1, Antwerp, Belgium.
  • Privat-Maldonado A; Research Group PLASMANT, Department of Chemistry, University of Antwerp, Antwerp, Belgium.
  • De Backer J; Research Group PPES, Department of Biomedical Sciences, University of Antwerp, Universiteitsplein 1, Antwerp, Belgium.
  • Shiratani M; Center of Plasma Nano-interface Engineering, Kyushu University, Fukuoka 819-0395, Japan; Graduate School of Information Science and Electrical Engineering, Kyushu University, Fukuoka 819-0395, Japan.
  • Choi EH; Department of Electrical and Biological Physics, Kwangwoon University, Seoul 01897, Republic of Korea.
  • Bogaerts A; Research Group PLASMANT, Department of Chemistry, University of Antwerp, Antwerp, Belgium.
Int J Biol Macromol ; 182: 1724-1736, 2021 Jul 01.
Article en En | MEDLINE | ID: mdl-34051258
Bacterial and mammalian proteins, such as lysozyme, are gaining increasing interest as anticancer drugs. This study aims to modify the lysozyme structure using cold atmospheric plasma to boost its cancer cell killing effect. We investigated the structure at acidic and neutral pH using various experimental techniques (circular dichroism, fluorescence, and mass spectrometry) and molecular dynamics simulations. The controlled structural modification of lysozyme at neutral pH enhances its activity, while the activity was lost at acidic pH at the same treatment conditions. Indeed, a larger number of amino acids were oxidized at acidic pH after plasma treatment, which results in a greater distortion of the lysozyme structure, whereas only limited structural changes were observed in lysozyme after plasma treatment at neutral pH. We found that the plasma-treated lysozyme significantly induced apoptosis to the cancer cells. Our results reveal that plasma-treated lysozyme could have potential as a new cancer cell killing drug.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Muramidasa / Gases em Plasma Tipo de estudio: Etiology_studies Límite: Humans Idioma: En Revista: Int J Biol Macromol Año: 2021 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Muramidasa / Gases em Plasma Tipo de estudio: Etiology_studies Límite: Humans Idioma: En Revista: Int J Biol Macromol Año: 2021 Tipo del documento: Article